• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初始和终末内髓集合管中环磷酸腺苷(cAMP)生成的调节

Regulation of cAMP production in initial and terminal inner medullary collecting ducts.

作者信息

Yasuda G, Jeffries W B

机构信息

Second Department of Internal Medicine, Yokohama City University School of Medicine, Japan.

出版信息

Kidney Int. 1998 Jul;54(1):80-6. doi: 10.1046/j.1523-1755.1998.00990.x.

DOI:10.1046/j.1523-1755.1998.00990.x
PMID:9648066
Abstract

BACKGROUND

The inner medullary collecting duct (IMCD) is composed of at least two functionally and morphologically distinct segments, the initial (IMCDi) and the terminal (IMCDt) portions. However, most studies of receptor signaling have been performed on cells obtained from the entire inner medulla. The purpose of this study was to determine whether the patterns of receptor-activated cAMP accumulation were different between these segments.

METHODS

We measured cAMP accumulation stimulated by vasopressin and isoproterenol, and the effect of epinephrine in freshly dissected IMCDi and IMCDt segments cultured and IMCDi and IMCDt cells in primary culture.

RESULTS

The maximum response to vasopressin was twofold higher in fresh IMCDt verus IMCDi (P < 0.05), however, it increased in cultured IMCDi by 40% verus fresh cells with no change in the response in fresh verus cultured IMCDt. The maximum response to isoproterenol was small in fresh cells but increased by five- and sixfold, respectively, in cultured IMCDi and IMCDt cells. alpha 2-Adrenoceptor stimulation almost completely inhibited both vasopressin and isoproterenol-stimulated cAMP accumulations in fresh IMCDi and IMCDt cells, but only partially inhibited either accumulation by 34 to 49% in cultured cells.

CONCLUSIONS

(1) IMCDi and IMCDt cells are both subject to vasopressin and alpha 2- and beta-adrenergic regulation of adenylyl cyclase activity; (2) the relative influence of beta-adrenergic, alpha 2-adrenergic and V2 receptors to affect cAMP accumulation is altered in primary culture versus freshly dissected IMCD segments, suggesting that caution must be exercised in the extrapolation of data from cultured IMCD cells to in vivo models.

摘要

背景

髓质内集合管(IMCD)由至少两个功能和形态不同的节段组成,即起始部(IMCDi)和终末部(IMCDt)。然而,大多数受体信号传导研究是在从整个髓质获得的细胞上进行的。本研究的目的是确定这些节段之间受体激活的环磷酸腺苷(cAMP)积累模式是否不同。

方法

我们测量了血管加压素和异丙肾上腺素刺激的cAMP积累,以及肾上腺素对新鲜分离的培养IMCDi和IMCDt节段以及原代培养的IMCDi和IMCDt细胞的影响。

结果

新鲜IMCDt对血管加压素的最大反应比IMCDi高两倍(P < 0.05),然而,培养的IMCDi中其反应比新鲜细胞增加了40%,而新鲜与培养的IMCDt中的反应没有变化。新鲜细胞对异丙肾上腺素的最大反应较小,但在培养的IMCDi和IMCDt细胞中分别增加了五倍和六倍。α2-肾上腺素能受体刺激几乎完全抑制了新鲜IMCDi和IMCDt细胞中血管加压素和异丙肾上腺素刺激的cAMP积累,但在培养细胞中仅部分抑制了其中任何一种积累,抑制率为34%至49%。

结论

(1)IMCDi和IMCDt细胞均受血管加压素以及α2-和β-肾上腺素能对腺苷酸环化酶活性的调节;(2)与新鲜分离的IMCD节段相比,原代培养中β-肾上腺素能、α2-肾上腺素能和V2受体对cAMP积累的相对影响发生了改变,这表明在将培养的IMCD细胞数据外推到体内模型时必须谨慎。

相似文献

1
Regulation of cAMP production in initial and terminal inner medullary collecting ducts.初始和终末内髓集合管中环磷酸腺苷(cAMP)生成的调节
Kidney Int. 1998 Jul;54(1):80-6. doi: 10.1046/j.1523-1755.1998.00990.x.
2
Adrenergic regulation of salt and fluid secretion in human medullary collecting duct cells.
Am J Physiol Renal Physiol. 2004 Oct;287(4):F639-48. doi: 10.1152/ajprenal.00448.2003. Epub 2004 Jun 29.
3
Effect of epinephrine on cAMP accumulation in cultured rat inner medullary collecting duct cells.肾上腺素对培养的大鼠髓质内集合管细胞中环磷酸腺苷积累的影响。
Am J Physiol. 1997 Feb;272(2 Pt 2):F192-7. doi: 10.1152/ajprenal.1997.272.2.F192.
4
Alpha-2 adrenergic receptors in inner medullary collecting duct cells of the rabbit kidney.兔肾内髓集合管细胞中的α-2肾上腺素能受体。
J Pharmacol Exp Ther. 1993 Feb;264(2):879-88.
5
The beta 1- and beta 2-adrenoceptor subtypes in cultured rat inner medullary collecting duct cells.培养的大鼠髓质内集合管细胞中的β1和β2肾上腺素能受体亚型
Am J Physiol. 1996 Sep;271(3 Pt 2):F762-9. doi: 10.1152/ajprenal.1996.271.3.F762.
6
Characterization of prazosin-sensitive alpha 2 B-adrenoceptors expressed by cultured rat IMCD cells.培养的大鼠内髓集合管细胞表达的对哌唑嗪敏感的α2B肾上腺素能受体的特性
Am J Physiol. 1991 Nov;261(5 Pt 2):F760-6. doi: 10.1152/ajprenal.1991.261.5.F760.
7
Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway.血管加压素诱导大鼠髓质内集合管产生一氧化氮依赖于磷酸肌醇途径的V2受体激活。
Am J Physiol Renal Physiol. 2007 Aug;293(2):F526-32. doi: 10.1152/ajprenal.00052.2007. Epub 2007 May 16.
8
Evidence for dual signaling pathways for V2 vasopressin receptor in rat inner medullary collecting duct.大鼠髓质内集合管中V2血管加压素受体双重信号通路的证据。
Am J Physiol. 1996 Apr;270(4 Pt 2):F623-33. doi: 10.1152/ajprenal.1996.270.4.F623.
9
Hormone and autacoid regulation of cAMP production in rat IMCD subsegments.大鼠内髓集合管亚节段中环磷酸腺苷(cAMP)生成的激素和自分泌调节
Am J Physiol. 1992 Aug;263(2 Pt 2):F319-27. doi: 10.1152/ajprenal.1992.263.2.F319.
10
Regulation of pendrin by cAMP: possible involvement in β-adrenergic-dependent NaCl retention.环磷酸腺苷对 pendrin 的调节:可能参与β-肾上腺素能依赖性 NaCl 潴留。
Am J Physiol Renal Physiol. 2012 May 1;302(9):F1180-7. doi: 10.1152/ajprenal.00403.2011. Epub 2012 Jan 18.

引用本文的文献

1
Change in kidney volume growth rate and renal outcomes of tolvaptan treatment in autosomal dominant polycystic kidney disease: post-hoc analysis of TEMPO 3:4 trial.托伐普坦治疗常染色体显性遗传性多囊肾病时肾体积生长速率的变化及肾脏转归:TEMPO 3:4试验的事后分析
Clin Exp Nephrol. 2025 May;29(5):638-649. doi: 10.1007/s10157-024-02589-1. Epub 2025 Jan 2.
2
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling.聚焦于环磷酸腺苷信号传导的常染色体显性多囊肾病新兴疗法
Front Mol Biosci. 2022 Sep 2;9:981963. doi: 10.3389/fmolb.2022.981963. eCollection 2022.
3
Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.
G 蛋白偶联受体和环 AMP 信号转导对多囊肾病的调节。
Cell Signal. 2020 Aug;72:109649. doi: 10.1016/j.cellsig.2020.109649. Epub 2020 Apr 23.
4
Management of autosomal-dominant polycystic kidney disease-state-of-the-art.常染色体显性多囊肾病的管理——最新进展
Clin Kidney J. 2018 Dec;11(Suppl 1):i2-i13. doi: 10.1093/ckj/sfy103. Epub 2018 Dec 17.
5
Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial.常染色体显性多囊肾病临床试验中的预后富集设计:TEMPO 3:4临床试验
Kidney Int Rep. 2016 Aug 6;1(4):213-220. doi: 10.1016/j.ekir.2016.08.001. eCollection 2016 Nov.
6
Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?探讨血管加压素拮抗剂在多囊肾病中的作用:从成人到儿童?
Pediatr Nephrol. 2018 Mar;33(3):395-408. doi: 10.1007/s00467-017-3672-x. Epub 2017 Apr 28.
7
Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial.托伐普坦在常染色体显性多囊肾病中的药代动力学和药效学:关键3期试验中剂量选择的2期试验
J Clin Pharmacol. 2017 Jul;57(7):906-917. doi: 10.1002/jcph.880. Epub 2017 Feb 20.
8
Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.血管加压素调节多囊性肝病中胆管上皮的生长。
Lab Invest. 2016 Nov;96(11):1147-1155. doi: 10.1038/labinvest.2016.93. Epub 2016 Aug 29.
9
Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies.磷酸二酯酶1和3亚家族对多囊肾病严重程度的调节作用
J Am Soc Nephrol. 2016 May;27(5):1312-20. doi: 10.1681/ASN.2015010057. Epub 2015 Sep 15.
10
Vasopressin and disruption of calcium signalling in polycystic kidney disease.血管加压素与多囊肾病中钙信号传导的破坏
Nat Rev Nephrol. 2015 Aug;11(8):451-64. doi: 10.1038/nrneph.2015.39. Epub 2015 Apr 14.